Aura Biosciences, Inc. — Director's Dealing 2021

Nov 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-11-02

Reporting Person: de los Pinos Elisabet (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-02	Common Stock	C	4552	$0.00	Acquired	131412	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-02	Series A-1 Preferred Stock	$	C	3042	Disposed		Common Stock (3042)	Indirect
2021-11-02	Series A-2 Preferred Stock	$	C	1510	Disposed		Common Stock (1510)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	74357	Direct

Footnotes

F1: The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021.

F2: The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.